The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling

K. Sully, O. Akinduro, M. P. Philpott, A. S. Naeem, C. A. Harwood, V. E. Reeve, R. F. O'Shaughnessy, C. Byrne

Research output: Contribution to journalArticle

19 Citations (Scopus)

Fingerprint Dive into the research topics of 'The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences